tiprankstipranks
Trending News
More News >
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market

Pacira Pharmaceuticals (PCRX) Technical Analysis

Compare
383 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Pacira Pharmaceuticals’s (PCRX) Moving Averages Convergence Divergence (MACD) indicator is -0.41, suggesting Pacira Pharmaceuticals is a Sell.
Pacira Pharmaceuticals’s (PCRX) 20-Day exponential moving average is 21.40, while Pacira Pharmaceuticals’s (PCRX) share price is $21.77, making it a Buy.
Pacira Pharmaceuticals’s (PCRX) 50-Day exponential moving average is 22.39, while Pacira Pharmaceuticals’s (PCRX) share price is $21.77, making it a Sell.

Pacira Pharmaceuticals (PCRX) Pivot Points

Feb 16, 2026, 08:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.33
20.81
21.13
21.61
21.93
22.41
22.73
Fibonacci
20.81
21.12
21.30
21.61
21.92
22.10
22.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pacira Pharmaceuticals (PCRX) Moving Averages

Feb 16, 2026, 08:52 PM
Period
Simple
Exponential
MA5
21.45Buy
21.46Buy
MA10
21.15Buy
21.24Buy
MA20
20.65Buy
21.40Buy
MA50
23.27Sell
22.39Sell
MA100
23.27Sell
23.13Sell
MA200
24.03Sell
23.82Sell
Pacira Pharmaceuticals’s (PCRX) 10-Day exponential moving average is 21.24, while Pacira Pharmaceuticals’s (PCRX) share price is $21.77, making it a Buy.
Pacira Pharmaceuticals’s (PCRX) 100-Day exponential moving average is 23.13, while Pacira Pharmaceuticals’s (PCRX) share price is $21.77, making it a Sell.
Pacira Pharmaceuticals’s (PCRX) stock price is $21.77 and Pacira Pharmaceuticals’s (PCRX) 50-day simple moving average is 23.27, creating a Sell signal.
Pacira Pharmaceuticals’s (PCRX) stock price is $21.77 and Pacira Pharmaceuticals’s (PCRX) 100-day simple moving average is 23.27, creating a Sell signal.
Pacira Pharmaceuticals’s (PCRX) stock price is $21.77 and Pacira Pharmaceuticals’s (PCRX) 200-day simple moving average is 24.03, creating a Sell signal.

Pacira Pharmaceuticals (PCRX) Technical Indicators

Feb 16, 2026, 08:52 PM
Name
Value
Implied Action
RSI (14)
50.84
Neutral
STOCH (9,6)
73.62
Neutral
STOCHRSI (14)
78.96
Neutral
MACD (12,26)
-0.41
Sell
ADX (14)
24.49
Neutral
Williams %R
-24.42
Buy
CCI (14)
155.13
Sell
ATR (14)
0.95
-
Ultimate Oscillator
46.93
Neutral
ROC
6.20
Buy
Pacira Pharmaceuticals’s (PCRX) Relative Strength Index (RSI) is 50.84, creating a Neutral signal.
Pacira Pharmaceuticals’s (PCRX) Trend Strength Indicator (ADX) is 24.49, creating a Neutral signal.
Pacira Pharmaceuticals’s (PCRX) Commodity Channel Index (CCI) is 155.13, creating a Sell signal.
Pacira Pharmaceuticals’s (PCRX) Price Rate of Change (ROC) is 6.20, creating a Buy signal.

FAQ

Is PCRX a Buy, Hold, or Sell?
Based on PCRX’s technical indicators, PCRX is a Hold.
    What is PCRX’s RSI (14)?
    PCRX’s RSI (14) is 50.84, which suggests PCRX is a Neutral.
      What is PCRX’s MACD?
      PCRX’s MACD is -0.41, which suggests PCRX is a Sell.
        What is PCRX’s 5-day moving average?
        PCRX’s 5-day moving average is 21.45, which suggests PCRX is a Buy.
          What is PCRX’s 20-day moving average?
          PCRX 20-day moving average is 20.65, which suggests PCRX is a Buy.
            What is PCRX’s 50-day moving average?
            PCRX’s 50-day moving average is 23.27, which suggests PCRX is a Sell.
              What is PCRX’s 200-day moving average?
              PCRX’s 200-day moving average is 24.03, which suggests PCRX is a Sell.
                What is PCRX’s Williams % R (14)?
                PCRX’s Williams % R (14) is -24.42, which suggests PCRX is a Buy.
                  What is PCRX’s CCI (14)?
                  PCRX’s CCI (14) is 155.13, which suggests PCRX is a Sell.